$DIGX Rolling Brief - Updated Apr 8, 2018. Extracts From

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
311
$DIGX Rolling Brief - Updated Apr 8, 2018. Extracts From Official Filings & PRs + Analysis From Observations [main updates in bold ].

Company portfolio comprises:

"Expressions Chiropractic & Rehab, PA" and "Expressions Property Limited, LP" - wholly owned subsidiaries located in Dallas and Cedar Hill, TX - currently operates two chiropractic and rehab centers in the Dallas-Fort Worth Metroplex area.

Management has developed a business plan which includes growth through the acquisition of existing chiropractic and rehabilitation centers in the Dallas-Fort Worth Metroplex area.

Management believes that they will be able to obtain the capital necessary to acquire multiple chiropractic and rehabilitation centers in the Dallas-Fort Worth Metroplex area - in effect “Branding” the "Expressions" name and specific operational characteristics of the company.

"Split Endings" - a wholly owned subsidiary - is an upscale beauty salon located in Cedar Hill, TX.

Management has developed a business plan which includes growth through the acquisition of privately owned salons and spas in the Dallas-Fort Worth Metroplex area.

Management believes that they will be able to obtain the capital necessary to acquire multiple privately owned salons and spas in the Dallas-Fort Worth Metroplex area - in effect “Branding” the "Split Endings" name and specific operational characteristics of the company.

The Company is also actively seeking out suitable mergers, acquisitions and/or joint ventures , which would enhance our company's value.

Company websites:

http://www.expressionschiropractic.com/

http://www.splitendings.com/welcome.html

$DIGX Share Structure - TA Verified Company Profile - Updates As At Mar 30, 2018:

Authorized Shares: 2,100,000,000 - as at Mar 30, 2018 [no change].

Outstanding Shares: 1,830,612,000 - as at Mar 30, 2018 [reduced by 30,000,000 since January 30, 2017] [no change]

Restricted: 208,800,000 - as at Mar 30, 2018 [no change].

Unrestricted: 1,621,812,000 - as at Mar 30, 2018 [no change].

Held at DTC: 1,440,941,334 - as at Mar 30, 2018 [425M retired since May 31, 2017 - 150M retired May 31 > Jul 31 - 275M retired Jul 31 > Oct 31 - total 425M = very good - not available to individual investors].

Float: 1,621,812,000 - as at Dec 30, 2017 [reduced by 50,000,000 since December 31, 2016].

TA share structure updated as at Mar 30, 2018 in a timely manner - no dilution in 2017 and 2018 to date confirmed yet again.

There has been no dilution in 2017 or in 2018.

The share structure has headroom between the A/S and the O/S and is not maxed out.

The O/S was actually reduced in 2017 - thereby increasing the headroom between the A/S and the O/S.

The 2017 Annual Report confirmed that no shares were issued for convertible debt in Q4. Only 15M total were issued in the whole of 2017.

The Attorney Opinion Letter for the 2017 Annual Report was filed and accepted on Mar 9, 2018

There is absolutely no need to even consider a reverse split (as experienced traders who specialize in stocks under .01 well know).

$DIGX was the highest banked profit stock for those that traded it correctly in 2017 due to its proven history of regular repeat runs on the excellent financial results each quarter.

A contemporaneous record of trading for every day in 2017 and to date in 2018 has been maintained here on Investors Hangout.

From my observations, a number of the most successful traders in the OTC have been creating an inventory of shares at the year bottom prices in Q4 2017, and so far in 2018, not only to trade on surges but also to deny as many shares as possible to low level flippers and to those that use disinformation and a stacked ask in attempts to get cheap shares.

320M shares have been bought at .0003 since Sep 15, 2017 - almost all by savvy traders who intentionally bid for them.

586M shares have been bought at .0004 since Aug 23, 2017 - almost all by traders who bought on the ask. Of these 172M have been in 2018 [including 51M bought in a few minutes on the ask on Jan 11 and 20M on Jan 19].

6M shares have been bought at .0005 since Jan 19, 2018 - all by traders who bought on the ask.

The 2017 Annual Report was filed 25 days early on March 6, 2018.

Proven, excellent financial results which set off several runs in 2017:

2017 Gross Revenue: $1,980,130.

2017 Gross Profit: $1,932,177.

2017 Net Profit: $234,138 [rare in the OTC].

As expected, Q4 revenue was up compared to the average of Q1>Q3.

All net profits are held as cash at the bank and therefore available for planned brand expansion and acquisitions [rare in the OTC].

The company is rated as a "Going Concern" [rare in the OTC].

Overall, $DIGX has generally filed quarterly reports in a timely manner in the modern era (since the acquisition of Expressions Chiropractic & Rehab in January 2016).

The filing of the 2017 Annual Report on Mar 6, 2018 - 25 days earlier than the 2016 Annual Report on Mar 31, 2017 - is noteworthy. The Attorney Opinion Letter followed in short order on Mar 9, 2018.

$DIGX is OTC Current and likely to remain so indefinitely.

There has never been any awareness campaign on $DIGX in the modern era - it is successful enough on its' filed financial performance to attract enthusiastic, high-volume, successful traders with a proven track record who have significant followings.

The Annual Report confirms that no shares have been issued in consideration of promotional campaigns.

Based on the 2017 cycle, we can expect to see:

A PR to the wider investment community highlighting the excellent results in the recently filed 2017 Annual Report. At present, it is mostly only current long-term investors specifically looking for the Annual Report who have seen it.

The 2018 Q1 results and a PR either before, after or both [filed on May 16, 2017 last year].

Further PR content outlining progress with implementation of the Strategic Growth Plan.

The first step was due to be increasing the range of services offered in all offices of the Expressions Chiropractic & Rehab chain thereby increasing the profitability of each location. That action has already yielded results with the anticipated increased profitability being delivered successfully in 2017 Q4.

The acquisition of additional already profitable locations that wanted to go public was also planned as part of the brand expansion.

More savvy, OTC market off-the-bottom specialist traders - who typically buy up to 150M > 300M at the first 2 to 3 available ask price points - out of the blue with no warning in seconds / minutes to ultimately get at least 100% > 150% per run - are likely to turn their attention to $DIGX again in the not so distant future due to its' repeat run performance. This has happened on at least one stock every week in 2018 so far - including coincidentally 3 of my long-term picks.Timing will - as always - depend on the dynamics of their other trades. It has been evident f or 2 weeks now that a few more were scaling in on the ask.

$DIGX remaining thin to the upside for a stock currently in the under .0010 price range with less than 10% of the 586M shares bought at .0004 likely to be on the ask at .0005. Only 12% of the shares bought at .0003 are shown as offered on the ask at .0004 - the majority of these are put up late as a day trade after the open each day and probably won't be there on any news or buying at open day .

The repeat whales in $DIGX loaded for a reason - to sell for at least 100%>150% from current levels on repeat runs over the whole course of 2018 . They don't care how long they have to wait.













American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
Anecdotes by Artists Brings Raw Scent Stories to Sephora

Updated Category News Views 3

When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 7

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 8

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
FJBio Boosts Antibody Discovery with Sapio AI

Updated Category News Views 5

In the sprawling world of antibody discovery, where every scrap of data can make or break the next big breakthrough, FairJourney Bio (FJBio) is pulling out all the stops. They've teamed up with Sapio Sciences to ditch the paperwork nightmares and usher in a new era of AI-driven efficiency. With operations stretching from Porto to Cambridge to sunny San Diego, they’re...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Reactions: Nike and Resources Connection Performance Insights

Updated Category News Views 48

Understanding Market Movements After Earnings Reports In the dynamic world of stock trading, after-hours performance can tell investors a lot about how companies are faring with their earnings announcements. Recently, notable corporations like Nike and Resources Connection saw significant stock movements in reaction to their quarterly earnings, stirring interest among...

Continue Reading
Heartwood Partners Completes Successful Sale of Sur-Seal

Updated Category News Views 258

Heartwood Partners Completes Sale of Sur-Seal Heartwood Partners is excited to share that Heartwood Partners III, LP and its affiliates have finalized the sale of Sur-Seal, LLC to Brodie Generational Capital Partners, an investment firm with a focus on long-term commitments to industrial companies. This marks an important milestone in Heartwood's expansive history. About...

Continue Reading
Geneoscopy Secures $105M Funding to Transform Diagnostics

Updated Category News Views 242

Geneoscopy Completes Series C Funding for Gastrointestinal Health Geneoscopy, Inc., a prominent life sciences company dedicated to enhancing gastrointestinal health through innovative diagnostic tests, has recently finalized a Series C funding round that garnered an impressive $105 million. This strategic investment, spearheaded by Bio-Rad Laboratories, not only bolsters...

Continue Reading
AIM ImmunoTech Invites Shareholders to Support Current Board

Updated Category News Views 82

AIM ImmunoTech Encourages Shareholder Participation AIM ImmunoTech Inc. (NYSE American: AIM) is calling on its valued shareholders to actively participate in an important upcoming event. With the 2024 Annual Meeting of Stockholders on the horizon, AIM is reminding everyone to make their voices heard by voting 'FOR' the incumbent members of its Board of Directors. Why...

Continue Reading
Understanding Short Interest Trends for Thermo Fisher Scientific

Updated Category News Views 148

Understanding Short Interest in Thermo Fisher Scientific Inc Thermo Fisher Scientific Inc (NYSE: TMO) has seen a notable increase in its short interest, which has risen by 10.78% since the last report. Recent data indicates that 4.27 million shares have been sold short, representing 1.13% of the total shares available for trading. Analyzing the trading volume, it appears...

Continue Reading